1. Applying the New Multiple Sclerosis Guidelines to Clinical Practice

3. The Need for ECTRIMS/EAN Clinical Practice Guidelines

4. Current Guidelines for MS Management

5. Rationale for New ECTRIMS-EAN Guidelines

6. Limitations of Guidelines for MS

7. Weighing the Evidence and Developing the Recommendations

8. Guideline Development: Key Concepts

9. Defining Expectations of the Treatment Center

10. Treatment Recommendations for CIS

11. Guideline Recommendations for Treating Active RRMS

12. Guideline Recommendations for Monitoring Disease Activity and Treatment Response

13. MRI Monitoring: MS Phenotype Group Consensus Recommendations

14. Guideline Recommendations for Patients With Inadequate Treatment Response

15. Guideline Recommendations for Treating Progressive Disease

16. Treatment Considerations During Pregnancy

17. Refining and Finalizing the ECTRIMS-EAN Guidelines

18. Updating the Guidelines as New Evidence Emerges

19. Using the Guidelines in Clinical Practice

20. Using the Guidelines Beyond Clinical Practice

21. ECTRIMS-EAN vs AAN Guidelines

22. Considerations for Stopping Therapy

23. Managing Patients With RRMS Under the New Guidelines: The Patient’s Perspective

24. Managing Patients With RRMS Under the New Guidelines: The Physician’s Perspective

25. Conclusions

26. Abbreviations